# FS KKR Capital Corp: overview FSK · NYSE · CIK 1422183 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fsk.md) · [Financials](/companies/fsk/financials.md) · [Filings](/companies/fsk/filings.md) · [Insiders](/companies/fsk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.57](/filings/0001628280-26-011734.md) | [0.52](/filings/0001628280-26-011734.md) | [0.43](/filings/0001628280-26-033118.md) | [(0.75)](/filings/0001628280-26-053783.md) | [0.76](/filings/0001628280-26-011734.md) | [(0.41)](/filings/0001628280-26-011734.md) | [(1.57)](/filings/0001628280-26-033118.md) | [(0.13)](/filings/0001628280-26-053783.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [7.16](/filings/0001628280-24-006912.md) | [0.32](/filings/0001628280-25-008175.md) | [2.48](/filings/0001628280-26-011734.md) | [2.09](/filings/0001628280-26-011734.md) | [0.04](/filings/0001628280-26-011734.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fsk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [OAK HILL ADVISORS LP](/funds/1164688.md) | 2026-06-30 | $119.4m | 11,371,693 | | Added +2,395,866 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $60.5m | 5,760,510 | | Reduced −32,254 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $56.5m | 5,382,748 | | Added +636,889 | | [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $52.8m | 5,032,014 | | Added +3,533,540 | | [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $51.1m | 4,868,176 | | Added +461,790 | | [Saba Capital Management, L.P.](/funds/1510281.md) | 2026-06-30 | $44.3m | 4,215,619 | | Added +705,871 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $30.2m | 2,877,758 | | Reduced −832,480 | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $28.7m | 2,735,984 | | Added +220,124 | | [Silver Point Capital L.P.](/funds/1332784.md) | 2026-06-30 | $28.6m | 2,724,000 | | New +2,724,000 | | [Generali Asset Management SPA SGR](/funds/2046751.md) | 2026-06-30 | $26.6m | 2,529,225 | | Reduced −17,146 | ## Recent filings [All 1,352 filings](/companies/fsk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-08 | 20:30 ET | [8-K](/filings/0001104659-26-114718.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-114718 | | 2026-08-20 | 20:38 ET | [8-K](/filings/0001104659-26-099250.md) | 5.07 Shareholder vote results | 0001104659-26-099250 | | 2026-08-13 | 20:15 ET | [8-K](/filings/0001104659-26-095932.md) | 7.01 Regulation FD disclosure | 0001104659-26-095932 | | 2026-08-06 | 10:42 ET | [8-K](/filings/0001104659-26-091572.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-091572 | | 2026-08-06 | 10:27 ET | [10-Q](/filings/0001628280-26-053783.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053783 | | 2026-07-09 | 20:27 ET | [8-K](/filings/0001104659-26-082282.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-082282 | | 2026-06-29 | 21:06 ET | [8-K](/filings/0001104659-26-078916.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-078916 | | 2026-06-23 | 22:54 ET | [SCHEDULE 13D](/filings/0001140361-26-026121.md) | Ownership report, active investor | 0001140361-26-026121 | | 2026-06-18 | 20:02 ET | [8-K](/filings/0001104659-26-075713.md) | 5.07 Shareholder vote results | 0001104659-26-075713 | | 2026-06-08 | 20:30 ET | [8-K](/filings/0001104659-26-071409.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-071409 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-011734.md), filed Feb 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1422183 - Tickers: FSK - Exchange: NYSE - SIC code: not reported - State of incorporation: MD - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.